INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Agentic AI delivers Impact Now, Even With Messy Trial Data

  Think your messy, siloed data means AI has to wait? Think again. See how agentic AI drives measurable value across clinical trials without waiting for perfect data.

• The Agentic AI Readiness Myths Costing Sponsors Time

  Many clinical organizations believe they must clean data and unify systems before adopting agentic AI. New approaches show teams can start now, create value faster, and improve readiness as they scale.

• How Modern Platforms Enable Connected Clinical Data Systems And Flexible Study Workflows

  Digital trials demand seamless data flow. APIs reduce manual work, improve oversight, and power flexible, connected study environments.

• Cutting Corners In RTSM Software Increases Speed...And RISK!

  Discover why true RTSM efficiency requires rigor, not shortcuts — highlighting how thoughtful processes and clear communication deliver speed without compromising quality or introducing avoidable risk.

• Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue

  9/25/2025

  Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.

• Trailblazing Clinical Drug Development In Dermatology

  1/6/2026

  AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

• Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  9/16/2024

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

• Do We Still Need Patients In Tomorrow's Trials?

  8/19/2024

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

• Operationalizing Qualified e-Signature In eConsent: A Practical Playbook For Global Trials

  7/1/2026

  Inconsistent country signature rules complicate consent and raise compliance risk. Learn a repeatable framework for scalable, inspection-ready eConsent.